drugset / Trial / NCT00127647
An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to evaluate the efficacy and safety of an investigational drug in adult patients with allergic rhinitis.
Timeline
- Start
- 2004-11
- Primary completion
- 2005-04
- Completion
- 2005-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 5 mg | Oral |
| Subject | Montelukast | Other / unclassified | 10 mg | Oral |
| Comparator | Pranlukast | Small molecule | 225 mg | Oral |